ArticleAmino acids2026
Spider peptides from Brachypelma smithi with slightly different amino acids at their C-terminal loops exert different insecticidal activities.
Article in Amino acids, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Proteomic characterization ofThe journal of venomous animals and toxins including tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The insecticidal molecules of spiders persistently evolve to ensure rapid paralysis of their prey, and the best molecules are transmitted to their progeny. Here, we cloned two insecticidal peptides, Bs2 and Bs3, from the venom glands of the theraphosid Brachypelma smithi. Bs2 and Bs3 are 90.2% identical, but they exhibit interesting structural differences at their C-termini, including a connecting disulfide bond (residues Cys15-Cys36 for Bs2 and Cys15-Cys30 for Bs3). The genomic origin of Bs2 and Bs3 may be a cause for gene duplication events. Moreover, Bs2 differs in two residues from Tal1 (95.1% identical), an insecticidal peptide, from the tarantula Tliltocatl albopilosus. Likewise, Bs3 is similar to Asp3a from Aphonopelma sp., a peptide that targets mammalian Cav (voltage-dependent Ca2 + channel), but it has not been tested in insects. Bs2 and Bs3 were cloned and recombinantly expressed in bacterial cells, and their paralytic effects were tested on three species of insects. The insecticidal peptide rBs2 with the connecting loop Cys15-Cys36 was significantly more insecticidal than that of rBs3 when affecting Galleria mellonella larvae (Lepidoptera). Yet, the insecticidal peptide rBs3 with the connecting loop Cys15-Cys30 was significantly more insecticidal than that of rBs2 when affecting Acheta domesticus nymph crickets (Orthoptera), and Gromphadorhina portentosa cockroaches (Blattodea). rBs2 and rBs3 structural models show a low-structured C-terminal in rBs3, which correlates with a more flexible amino acid sequence of such C-terminal from residues Tyr30 to Leu42. Since insecticidal spider peptides are constantly evolving for prey capture, they are valuable ion channel antagonists for understanding insect cell receptors, and they are also promising leads for insect control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.